The history of Viagra and its creator , copyright, presents a complex picture for prospective investors. While the iconic drug initially generated enormous earnings, its patent has lapsed , leading to generic alternatives flooding the landscape . This decline in value presents a real obstacle for copyright and any company considering a large holdin